Literature DB >> 9636206

Inactivation of tyrosine hydroxylase by nitration following exposure to peroxynitrite and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).

J Ara1, S Przedborski, A B Naini, V Jackson-Lewis, R R Trifiletti, J Horwitz, H Ischiropoulos.   

Abstract

The decrement in dopamine levels exceeds the loss of dopaminergic neurons in Parkinson's disease (PD) patients and experimental models of PD. This discrepancy is poorly understood and may represent an important event in the pathogenesis of PD. Herein, we report that the rate-limiting enzyme in dopamine synthesis, tyrosine hydroxylase (TH), is a selective target for nitration following exposure of PC12 cells to either peroxynitrite or 1-methyl-4-phenylpyridiniun ion (MPP+). Nitration of TH also occurs in mouse striatum after MPTP administration. Nitration of tyrosine residues in TH results in loss of enzymatic activity. In the mouse striatum, tyrosine nitration-mediated loss in TH activity parallels the decline in dopamine levels whereas the levels of TH protein remain unchanged for the first 6 hr post MPTP injection. Striatal TH was not nitrated in mice overexpressing copper/zinc superoxide dismutase after MPTP administration, supporting a critical role for superoxide in TH tyrosine nitration. These results indicate that tyrosine nitration-induced TH inactivation and consequently dopamine synthesis failure, represents an early and thus far unidentified biochemical event in MPTP neurotoxic process. The resemblance of the MPTP model with PD suggests that a similar phenomenon may occur in PD, influencing the severity of parkisonian symptoms.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9636206      PMCID: PMC22714          DOI: 10.1073/pnas.95.13.7659

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  38 in total

1.  The absolute number of nerve cells in substantia nigra in normal subjects and in patients with Parkinson's disease estimated with an unbiased stereological method.

Authors:  B Pakkenberg; A Møller; H J Gundersen; A Mouritzen Dam; H Pakkenberg
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-01       Impact factor: 10.154

2.  Transgenic mice with increased Cu/Zn-superoxide dismutase activity are resistant to N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity.

Authors:  S Przedborski; V Kostic; V Jackson-Lewis; A B Naini; S Simonetti; S Fahn; E Carlson; C J Epstein; J L Cadet
Journal:  J Neurosci       Date:  1992-05       Impact factor: 6.167

3.  Measurement of tyrosine hydroxylase apoenzyme protein by enzyme-linked immunosorbent assay (ELISA): effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on striatal tyrosine hydroxylase activity and content.

Authors:  J F Reinhard; J P O'Callaghan
Journal:  Anal Biochem       Date:  1991-08-01       Impact factor: 3.365

4.  Nitric oxide and peroxynitrite-mediated pulmonary cell death.

Authors:  A J Gow; S R Thom; H Ischiropoulos
Journal:  Am J Physiol       Date:  1998-01

5.  Iron and aluminum increase in the substantia nigra of patients with Parkinson's disease: an X-ray microanalysis.

Authors:  E C Hirsch; J P Brandel; P Galle; F Javoy-Agid; Y Agid
Journal:  J Neurochem       Date:  1991-02       Impact factor: 5.372

6.  Dose-dependent destruction of the coeruleus-cortical and nigral-striatal projections by MPTP.

Authors:  N A Seniuk; W G Tatton; C E Greenwood
Journal:  Brain Res       Date:  1990-09-10       Impact factor: 3.252

7.  Inactivation of tyrosine hydroxylase in rat striatum by 1-methyl-4-phenylpyridinium ion (MPP+).

Authors:  N Ozaki; D Nakahara; M Mogi; M Harada; K Kiuchi; N Kaneda; Y Miura; Y Kasahara; T Nagatsu
Journal:  Neurosci Lett       Date:  1988-02-29       Impact factor: 3.046

8.  Predicted amino acid sequence of bovine tyrosine hydroxylase and its similarity to tyrosine hydroxylases from other species.

Authors:  S Saadat; A D Stehle; A Lamouroux; J Mallet; H Thoenen
Journal:  J Neurochem       Date:  1988-08       Impact factor: 5.372

9.  Change of tyrosine hydroxylase in the parkinsonian brain and in the brain of MPTP-treated mice as revealed by homospecific activity.

Authors:  T Nagatsu
Journal:  Neurochem Res       Date:  1990-04       Impact factor: 3.996

10.  A rapid and sensitive assay for tyrosine-3-monooxygenase based upon the release of 3H2O and adsorption of [3H]-tyrosine by charcoal.

Authors:  J F Reinhard; G K Smith; C A Nichol
Journal:  Life Sci       Date:  1986-12-08       Impact factor: 5.037

View more
  101 in total

1.  Early and late molecular events in neurodegeneration and neuroprotection in Parkinson's disease MPTP model as assessed by cDNA microarray; the role of iron.

Authors:  Moussa B.H. Youdim; Edna Grünblatt; Yona Levites; Gila Maor; Silvia Mandel
Journal:  Neurotox Res       Date:  2002 Nov-Dec       Impact factor: 3.911

Review 2.  Endogenous generation of reactive oxidants and electrophiles and their reactions with DNA and protein.

Authors:  Lawrence J Marnett; James N Riggins; James D West
Journal:  J Clin Invest       Date:  2003-03       Impact factor: 14.808

Review 3.  Glial cell response: A pathogenic factor in Parkinson's disease.

Authors:  Du Chu Wu; Kim Tieu; Oren Cohen; Dong-Kug Choi; Miquel Vila; Vernice Jackson-Lewis; Peter Teismann; Serge Przedborski
Journal:  J Neurovirol       Date:  2002-12       Impact factor: 2.643

4.  Early and late gene changes in MPTP mice model of Parkinson's disease employing cDNA microarray.

Authors:  Silvia Mandel; Edna Grünblatt; Gila Maor; Moussa B H Youdim
Journal:  Neurochem Res       Date:  2002-10       Impact factor: 3.996

5.  NADPH oxidase mediates oxidative stress in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease.

Authors:  Du-Chu Wu; Peter Teismann; Kim Tieu; Miquel Vila; Vernice Jackson-Lewis; Harry Ischiropoulos; Serge Przedborski
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-29       Impact factor: 11.205

6.  Identification of nitrotyrosine containing peptides using combined fractional diagonal chromatography (COFRADIC) and off-line nano-LC-MALDI.

Authors:  Trine R Larsen; Nicolai Bache; Jan Bert Gramsbergen; Peter Roepstorff
Journal:  J Am Soc Mass Spectrom       Date:  2011-03-08       Impact factor: 3.109

Review 7.  Early diagnosis and therapy of Parkinson's disease: can disease progression be curbed?

Authors:  Sagar Kansara; Akash Trivedi; Sheng Chen; Joseph Jankovic; Weidong Le
Journal:  J Neural Transm (Vienna)       Date:  2012-06-26       Impact factor: 3.575

Review 8.  Mechanisms of MDMA (ecstasy)-induced oxidative stress, mitochondrial dysfunction, and organ damage.

Authors:  Byoung-Joon Song; Kwan-Hoon Moon; Vijay V Upreti; Natalie D Eddington; Insong J Lee
Journal:  Curr Pharm Biotechnol       Date:  2010-08       Impact factor: 2.837

9.  Dopamine selectively sensitizes dopaminergic neurons to rotenone-induced apoptosis.

Authors:  Ferogh A Ahmadi; Tom N Grammatopoulos; Andy M Poczobutt; Susan M Jones; Laurence D Snell; Mita Das; W Michael Zawada
Journal:  Neurochem Res       Date:  2007-11-10       Impact factor: 3.996

Review 10.  Oxidative stress in Parkinson's disease: a mechanism of pathogenic and therapeutic significance.

Authors:  Chun Zhou; Yong Huang; Serge Przedborski
Journal:  Ann N Y Acad Sci       Date:  2008-12       Impact factor: 5.691

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.